195 related articles for article (PubMed ID: 2128566)
21. Neutralizing capacity of antisera raised in horses and rabbits against Crotalus durissus terrificus (South American rattlesnake) venom and its main toxin, crotoxin.
Oshima-Franco Y; Hyslop S; Prado-Franceschi J; Cruz-Höfling MA; Rodrigues-Simioni L
Toxicon; 1999 Oct; 37(10):1341-57. PubMed ID: 10414861
[TBL] [Abstract][Full Text] [Related]
22. Immunochemical cross-reactivity of two phospholipase A2 neurotoxins, agkistrodotoxin and crotoxin.
Choumet V; Jiang MS; Specker I; Bon C
Toxicon; 1991; 29(4-5):441-51. PubMed ID: 1862520
[TBL] [Abstract][Full Text] [Related]
23. Preparation of a crotoxin neutralizing monoclonal antibody.
Kaiser II; Middlebrook JL
Toxicon; 1988; 26(9):855-65. PubMed ID: 3201488
[TBL] [Abstract][Full Text] [Related]
24. Presynaptic actions of Mojave toxin isolated from Mojave rattlesnake (crotalus scutulatus) venom.
Ho CL; Lee CY
Toxicon; 1981; 19(6):889-92. PubMed ID: 7336451
[No Abstract] [Full Text] [Related]
25. Anti-sera raised in rabbits against crotoxin and phospholipase A2 from Crotalus durissus cascavella venom neutralize the neurotoxicity of the venom and crotoxin.
Beghini DG; Hernandez-Oliveira S; Rodrigues-Simioni L; Novello JC; Hyslop S; Marangoni S
Toxicon; 2004 Aug; 44(2):141-8. PubMed ID: 15246761
[TBL] [Abstract][Full Text] [Related]
26. A functional and thromboelastometric-based micromethod for assessing crotoxin anticoagulant activity and antiserum relative potency against Crotalus durissus terrificus venom.
Prezoto BC; Tanaka-Azevedo AM; Marcelino JR; Tashima AK; Nishiduka ES; Kapronezai J; Mota JO; Rocha MMT; Serino-Silva C; Oguiura N
Toxicon; 2018 Jun; 148():26-32. PubMed ID: 29654870
[TBL] [Abstract][Full Text] [Related]
27. Mojave toxin: rapid purification, heterogeneity and resistance to denaturation by urea.
Johnson GR; Bieber AL
Toxicon; 1988; 26(4):337-51. PubMed ID: 3406946
[TBL] [Abstract][Full Text] [Related]
28. Crotoxin, a phospholipase A2 neurotoxin from the South American rattlesnake Crotalus durissus terrificus: purification of several isoforms and comparison of their molecular structure and of their biological activities.
Faure G; Bon C
Biochemistry; 1988 Jan; 27(2):730-8. PubMed ID: 3349062
[TBL] [Abstract][Full Text] [Related]
29. Venom variability and envenoming severity outcomes of the Crotalus scutulatus scutulatus (Mojave rattlesnake) from Southern Arizona.
Massey DJ; Calvete JJ; Sánchez EE; Sanz L; Richards K; Curtis R; Boesen K
J Proteomics; 2012 May; 75(9):2576-87. PubMed ID: 22446891
[TBL] [Abstract][Full Text] [Related]
30. Isolation, stabilization, and characterization of a toxin from timber rattlesnake venom.
Sullivan J; Geren CR
Prep Biochem; 1979; 9(3):321-33. PubMed ID: 471946
[TBL] [Abstract][Full Text] [Related]
31. Disintegrin, hemorrhagic, and proteolytic activities of Mohave rattlesnake, Crotalus scutulatus scutulatus venoms lacking Mojave toxin.
Sánchez EE; Galán JA; Powell RL; Reyes SR; Soto JG; Russell WK; Russell DH; Pérez JC
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Jun; 141(2):124-32. PubMed ID: 16005687
[TBL] [Abstract][Full Text] [Related]
32. The effects of hybridization on divergent venom phenotypes: Characterization of venom from Crotalus scutulatus scutulatus × Crotalus oreganus helleri hybrids.
Smith CF; Mackessy SP
Toxicon; 2016 Sep; 120():110-23. PubMed ID: 27496060
[TBL] [Abstract][Full Text] [Related]
33. Biological and Proteolytic Variation in the Venom of Crotalus scutulatus scutulatus from Mexico.
Borja M; Neri-Castro E; Castañeda-Gaytán G; Strickland JL; Parkinson CL; Castañeda-Gaytán J; Ponce-López R; Lomonte B; Olvera-Rodríguez A; Alagón A; Pérez-Morales R
Toxins (Basel); 2018 Jan; 10(1):. PubMed ID: 29316683
[TBL] [Abstract][Full Text] [Related]
34. P9a(Cdt-PLA2) from Crotalus durissus terrificus as good immunogen to be employed in the production of crotalic anti-PLA2 IgG.
Fusco LS; Rodríguez JP; Torres-Huaco F; Huancahuire-Vega S; Teibler P; Acosta O; Marangoni S; Ponce-Soto LA; Leiva LC
Toxicol Lett; 2015 Oct; 238(1):7-16. PubMed ID: 26129711
[TBL] [Abstract][Full Text] [Related]
35. The origin of the diversity of crotoxin isoforms in the venom of Crotalus durissus terrificus.
Faure G; Choumet V; Bouchier C; Camoin L; Guillaume JL; Monegier B; Vuilhorgne M; Bon C
Eur J Biochem; 1994 Jul; 223(1):161-4. PubMed ID: 8033889
[TBL] [Abstract][Full Text] [Related]
36. Physiological and immunological properties of small myotoxins from the venom of the midget faded rattlesnake (Crotalus viridis concolor).
Ownby CL; Aird SD; Kaiser II
Toxicon; 1988; 26(3):319-23. PubMed ID: 3134753
[TBL] [Abstract][Full Text] [Related]
37. Hemorrhagic and Mojave toxins in the venoms of the offspring of two Mojave rattlesnakes (Crotalus scutulatus scutulatus).
Rael ED; Lieb CS; Maddux N; Varela-Ramirez A; Perez J
Comp Biochem Physiol B; 1993 Nov; 106(3):595-600. PubMed ID: 8281754
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the biological and immunological properties of fractions of prairie rattlesnake (Crotalus viridis viridis) venom.
Ownby CL; Colberg TR
Toxicon; 1987; 25(12):1329-42. PubMed ID: 3125631
[TBL] [Abstract][Full Text] [Related]
39. Isolation, enzymatic characterization and antiedematogenic activity of the first reported rattlesnake hyaluronidase from Crotalus durissus terrificus venom.
Bordon KC; Perino MG; Giglio JR; Arantes EC
Biochimie; 2012 Dec; 94(12):2740-8. PubMed ID: 22940594
[TBL] [Abstract][Full Text] [Related]
40. Characterization of anti-crotalic antibodies.
Guidolin FR; Tambourgi DV; Guidolin R; Marcelino JR; Okamoto CK; Magnoli FC; Queiroz GP; Dias da Silva W
Toxicon; 2013 May; 66():7-17. PubMed ID: 23402840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
